REGULATORY

PMDA to Continue Remote GCP/Compliance Inspections through June Next Year

December 7, 2020

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

The Pharmaceuticals and Medical Devices Agency (PMDA) will continue conducting remote GCP on-site inspections and paper-based compliance inspections until the end of June next year. The agency expects to announce next March whether it will continue remote inspections after that…

To read the full story

PMDA to Continue Remote GCP/Compliance Inspections through End of March 2021
September 24, 2020

REGULATORY

Govt’s Honebuto Draft Confirms FY2027 Off-Year Drug Price Revision
July 1, 2026
Govt Presents Growth Strategy Draft Ahead of July Approval
July 1, 2026
Lower House Clears Immunization Act Revision
July 1, 2026
LDP Cautious over Ishin’s GDP-Linked Healthcare Spending Proposal
July 1, 2026
Japan Begins Review of Domestic CGT Seeds with Limited Market Potential
June 30, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COLUMN

The Psychology of ‘Stuck’: Understanding Why Changing Jobs Feels So Hard

By Philip Carrigan

Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…

COMMENTARY

Adaptation, Diversification Key as Drug Wholesalers Face Profit Squeeze

By Tatsuya Otsuka

Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…